Evidence map›Paper›PMID 29272385›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Surveillance for and Discovery of Borrelia Species in US Patients Suspected of Tickborne Illness.

Luke C Kingry, Melissa Anacker, Bobbi Pritt, Jenna Bjork, Laurel Respicio-Kingry, Gongping Liu, Sarah Sheldon, David Boxrud, Anna Strain, Stephanie Oatman and 6 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. High-qualityMicrobiology spectrum · 2026
    Article
  4. Frontiers in immunology · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Prevalence of Lyme Disease and Relapsing FeverPathogens (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Luke C KingryDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado.
Melissa AnackerMinnesota Department of Health, St Paul.
Bobbi PrittMayo Clinic, Rochester, Minnesota.
Jenna BjorkMinnesota Department of Health, St Paul.
Laurel Respicio-KingryDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado.
Gongping LiuMinnesota Department of Health, St Paul.
Sarah SheldonDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado.
David BoxrudMinnesota Department of Health, St Paul.
Anna StrainMinnesota Department of Health, St Paul.
Stephanie OatmanDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado.
Jon BerryMayo Clinic, Rochester, Minnesota.
Lynne SloanMayo Clinic, Rochester, Minnesota.
Paul MeadDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado.
David NeitzelMinnesota Department of Health, St Paul.
Kiersten J KugelerDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado.
Jeannine M PetersenDivision of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Background: Tick-transmitted Borrelia fall into 2 heterogeneous bacterial complexes comprised of multiple species, the relapsing fever (RF) group and the Borrelia burgdorferi sensu lato group, which are the causative agents of Lyme borreliosis (LB), the most common tickborne disease in the Northern Hemisphere. Geographic expansion of LB in the United States and discovery of emerging Borrelia pathogens underscores the importance of surveillance for disease-causing Borrelia. Methods: De-identified clinical specimens, submitted by providers throughout the United States, for patients suspected of LB, anaplasmosis, ehrlichiosis, or babesiosis were screened using a Borrelia genus-level TaqMan polymerase chain reaction (PCR). Borrelia species and sequence types (STs) were characterized by multilocus sequence typing (MLST) utilizing next-generation sequencing. Results: Among 7292 specimens tested, 5 Borrelia species were identified: 2 causing LB, B. burgdorferi (n = 25) and B. mayonii (n = 9), and 3 RF borreliae, B. hermsii (n = 1), B. miyamotoi (n = 8), and Candidatus B. johnsonii (n = 1), a species previously detected only in the bat tick, Carios kelleyi. ST diversity was greatest for B. burgdorferi-positive specimens, with new STs identified primarily among synovial fluids. Conclusions: These results demonstrate that broad PCR screening followed by MLST is a powerful surveillance tool for uncovering the spectrum of disease-causing Borrelia species, understanding their geographic distribution, and investigating the correlation between B. burgdorferi STs and joint involvement. Detection of Candidatus B. johnsonii in a patient with suspected tickborne disease suggests this species may be a previously undetected cause of illness in humans exposed to bat ticks.

Indexed as

Epidemiological MonitoringAnimalsBacterial Typing TechniquesBorreliaBorrelia burgdorferi GroupChiropteraGeographyHigh-Throughput Nucleotide SequencingHumansIxodesLyme DiseaseMultilocus Sequence TypingPolymerase Chain ReactionTick-Borne DiseasesUnited States

Identifiers

PMID29272385
PMCPMC5985202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.